GATA2 deficiency phenotype associated with tandem duplication of GATA2 and overexpression of GATA2-AS1.


Journal

Blood advances
ISSN: 2473-9537
Titre abrégé: Blood Adv
Pays: United States
ID NLM: 101698425

Informations de publication

Date de publication:
28 12 2021
Historique:
received: 19 05 2021
accepted: 20 09 2021
pubmed: 13 10 2021
medline: 8 1 2022
entrez: 12 10 2021
Statut: ppublish

Résumé

A 3-year-old girl of nonconsanguineous healthy parents presented with cervical and mediastinal lymphadenopathy due to Mycobacterium fortuitum infection. Routine blood analysis showed normal hemoglobin, neutrophils, and platelets but profound mononuclear cell deficiency (monocytes < 0.1 × 109/L; B cells 78/μL; NK cells 48/μL). A 548 902-bp region containing GATA2 was sequenced by targeted capture and deep sequencing. This revealed a de novo 187-kb duplication of the entire GATA2 locus, containing a maternally inherited copy number variation deletion of 25 kb (GRCh37: esv2725896 and nsv513733). Many GATA2-associated phenotypes have been attributed to amino acid substitution, frameshift/deletion, loss of intronic enhancer function, or aberrant splicing. Gene deletion has been described, but other structural variation has not been reported in the germline configuration. In this case, duplication of the GATA2 locus was paradoxically associated with skewed diminished expression of GATA2 messenger RNA and loss of GATA2 protein. Chimeric RNA fusion transcripts were not detected. A possible mechanism involves increased transcription of the anti-sense long noncoding RNA GATA2-AS1 (RP11-472.220), which was increased several fold. This case further highlights that evaluation of the allele count is essential in any case of suspected GATA2-related syndrome.

Identifiants

pubmed: 34638133
pii: 477263
doi: 10.1182/bloodadvances.2021005217
pmc: PMC8714714
doi:

Substances chimiques

GATA2 Transcription Factor 0
GATA2 protein, human 0

Types de publication

Case Reports Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

5631-5635

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/P002005/1
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 206103/Z/17/Z
Pays : United Kingdom

Informations de copyright

© 2021 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.

Références

Bioinformatics. 2009 Jul 15;25(14):1754-60
pubmed: 19451168
Blood. 2011 Sep 8;118(10):2653-5
pubmed: 21670465
Nat Genet. 2011 Sep 04;43(10):1012-7
pubmed: 21892162
Genome Res. 2021 Mar;31(3):448-460
pubmed: 33441414
Neoplasma. 2019 Nov;66(6):954-962
pubmed: 31607132
Cancer Res. 2016 Jan 15;76(2):216-26
pubmed: 26552699
Blood. 2014 Feb 6;123(6):863-74
pubmed: 24345756
Leukemia. 2018 Nov;32(11):2502-2507
pubmed: 29749400
Blood. 2009 Mar 19;113(12):2661-72
pubmed: 19168794
Haematologica. 2018 Aug;103(8):1278-1287
pubmed: 29724903
Blood. 2020 Jul 9;136(2):224-234
pubmed: 32219447
Nat Immunol. 2013 Jul;14(7):756-63
pubmed: 23708252
Blood. 2014 Feb 6;123(6):809-21
pubmed: 24227816
Nat Genet. 2011 Sep 04;43(10):929-31
pubmed: 21892158
Leukemia. 2020 Oct;34(10):2673-2687
pubmed: 32555368
Blood. 2011 Sep 8;118(10):2656-8
pubmed: 21765025
Blood. 2016 Mar 17;127(11):1387-97; quiz 1518
pubmed: 26702063
J Pediatr Hematol Oncol. 2018 May;40(4):e225-e228
pubmed: 29620682
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
Cell. 2014 Apr 10;157(2):369-381
pubmed: 24703711
Nature. 2015 Oct 1;526(7571):68-74
pubmed: 26432245
Nat Biotechnol. 2011 Jan;29(1):24-6
pubmed: 21221095
Hum Genet. 2020 Jun;139(6-7):993-1000
pubmed: 32025907
Cell Death Dis. 2019 Aug 8;10(8):599
pubmed: 31395854
Bioinformatics. 2014 Dec 15;30(24):3443-50
pubmed: 25016581

Auteurs

Preeti Singh (P)

Newcastle University Translational and Clinical Research Institute and NIHR Newcastle Biomedical Research Centre, Newcastle upon Tyne, United Kingdom.

Maninder Heer (M)

Newcastle University Translational and Clinical Research Institute and NIHR Newcastle Biomedical Research Centre, Newcastle upon Tyne, United Kingdom.

Anastasia Resteu (A)

Newcastle University Translational and Clinical Research Institute and NIHR Newcastle Biomedical Research Centre, Newcastle upon Tyne, United Kingdom.

Aneta Mikulasova (A)

Newcastle University Biosciences Institute, Newcastle upon Tyne, United Kingdom.

Mojgan Reza (M)

Newcastle University Translational and Clinical Research Institute and NIHR Newcastle Biomedical Research Centre, Newcastle upon Tyne, United Kingdom.

Laëtitia Largeaud (L)

Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France.

Stéphanie Dufrechou (S)

Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France.

Naïs Prade (N)

Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France.

Rachel E Dickinson (RE)

Newcastle University Translational and Clinical Research Institute and NIHR Newcastle Biomedical Research Centre, Newcastle upon Tyne, United Kingdom.

Jacinta Bustamante (J)

Laboratory of Human Genetics of Infectious Diseases, Necker Branch INSERM U1163, Paris, France.
Imagine Institute, Descartes University, Paris, France; and.

Bénédicte Neven (B)

Laboratory of Human Genetics of Infectious Diseases, Necker Branch INSERM U1163, Paris, France.

Venetia Bigley (V)

Newcastle University Translational and Clinical Research Institute and NIHR Newcastle Biomedical Research Centre, Newcastle upon Tyne, United Kingdom.

Eric Delabesse (E)

Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France.

Daniel Rico (D)

Newcastle University Biosciences Institute, Newcastle upon Tyne, United Kingdom.

Marlène Pasquet (M)

Pediatric Hematology-Immunology, Centre Hospitalier Universitaire de Toulouse, Toulouse, France.

Matthew Collin (M)

Newcastle University Translational and Clinical Research Institute and NIHR Newcastle Biomedical Research Centre, Newcastle upon Tyne, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH